TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Life Genomics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,594
|
29,974
|
45,802 |
| Financial expenses |
2
|
1
|
88 |
| Earnings before taxes |
-1,911
|
-5,169
|
-30,303 |
| EBITDA |
-1,959
|
-4,936
|
-24,620 |
| Total assets |
24,011
|
25,872
|
43,356 |
| Current assets |
23,192
|
24,656
|
41,707 |
| Current liabilities |
5,390
|
5,339
|
17,655 |
| Equity capital |
18,621
|
20,533
|
25,701 |
| - share capital |
451
|
451
|
451 |
| Employees (average) |
7
|
10
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
79.4%
|
59.3% |
| Turnover per employee |
4,228
|
2,997
|
2,545 |
| Profit as a percentage of turnover |
-6.5%
|
-17.2%
|
-66.2% |
| Return on assets (ROA) |
-8.0%
|
-20.0%
|
-69.7% |
| Current ratio |
430.3%
|
461.8%
|
236.2% |
| Return on equity (ROE) |
-10.3%
|
-25.2%
|
-117.9% |
| Change turnover |
-380
|
-15,828
|
-77,009 |
| Change turnover % |
-1%
|
-35%
|
-63% |
| Chg. No. of employees |
-3
|
-8
|
-5 |
| Chg. No. of employees % |
-30%
|
-44%
|
-22% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.